Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome-dependent pyroptosis
29 August 2020 (00:00 - 00:00)
Organised by:
About the speaker

Zhongshan Hospital Fudan University, Shanghai (China)
6 More presentations in this session
Doctor R. Kanji (London, GB)
Doctor C. Vandenbriele (London, GB)
Mr T. Hofbauer (Vienna, AT)
Access the full session
The Event
ESC Congress 2020
29 August - 1 September 2020
